Get started
Work

MA09.02 In Vivo, Ex Vivo and Early Clinical Activity of EGFR Monoclonal Antibody and Osimertinib in EGFR Exon 20 Insertion NSCLC

Year: 2019
Type: conference-abstract
DOI: 10.1016/j.jtho.2019.08.566
Authors: J. Riess, N. Floch, P. Mack, M. Martin, D. Vang, P. Smith, D. Cross, M. Cheng, J. Keck, S. Groshen, M. Rabin, S. Padda, G. Oxnard, J. Sands, K. Ramchandran, M. Koczywas, J. Moscow, P. Jänne, P. Lara, E. Newman, D. Gandara
Institutions: UC Davis Comprehensive Cancer Center, AstraZeneca (United Kingdom), Jackson Laboratory, USC Norris Comprehensive Cancer Center, Dana-Farber Cancer Institute, Stanford Cancer Institute, City Of Hope National Medical Center, City of Hope, National Institutes of Health, National Cancer Institute
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2981609727
Cites:
Cited by:
Related to: 10